Company Of The Day: Pfizer

by Trefis Team
+20.12%
Upside
43.15
Market
51.83
Trefis
PFE
Pfizer
Rate   |   votes   |   Share

What?

Pfizer’s (NYSE:PFE) Covid-19 vaccine could be available to children from ages five to eleven as soon as the end of October, per a report from Reuters.

Why?

Pfizer and its partner BioNTech could have sufficient data from clinical trials for the age group to file for emergency use authorization (EUA) by the end of this month.

So What?

Pfizer stock remains up by about 21% year-to-date, driven by soaring demand for the Covid-19 vaccine. A potential approval for children should expand the addressable market for the shot further.

See Our Complete Analysis For Pfizer

Rate   |   votes   |   Share

Comments

Name (Required)
Email (Required, but never displayed)
Be the first to comment!